SCHEDULE 13G/A: BlackRock Maintains Significant 8% Stake in CareDx Inc.

BlackRock, Inc. has filed an amended Schedule 13G, confirming its continued beneficial ownership of 8.0% of CareDx Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 4,416,324 shares of CareDx Inc. common stock.
• This ownership represents 8.0% of the total outstanding common stock of CareDx Inc.
• BlackRock holds sole voting power over 4,323,315 shares and sole dispositive power over 4,416,324 shares.
• The filing is an Amendment No. 7 to a Schedule 13G, indicating a passive investment not intended to influence or change control of the issuer.
• The securities are held in the ordinary course of business by various business units of BlackRock, Inc. and its subsidiaries and affiliates.

Sentiment

Score: 5

Explanation: The document is a factual, routine disclosure of beneficial ownership by a passive institutional investor. It contains no positive or negative operational or financial news about the issuer, CareDx Inc., and therefore has a neutral sentiment.

Positives

• The continued significant stake by BlackRock, a major institutional investor, may signal ongoing institutional confidence in CareDx Inc.

Future Outlook

The document is a beneficial ownership statement and does not contain any forward-looking statements or guidance regarding CareDx Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the current holding.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing reflects the routine disclosure practices of large institutional asset managers like BlackRock, which frequently hold significant, passive stakes in publicly traded companies across various industries, including healthcare technology like CareDx Inc. It indicates continued institutional interest in the company.

Stakeholder Impact

• For shareholders, BlackRock's continued significant stake may be viewed as a sign of stability and institutional confidence in CareDx Inc.

Next Steps

• BlackRock, Inc. will continue to file amendments to this Schedule 13G if there are material changes to its beneficial ownership of CareDx Inc. common stock, as required by SEC regulations.

Key Dates

Keywords

CareDx Inc, BlackRock Inc, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment